Business Description
Coegin Pharma
ISIN : SE0020357754
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.85 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 57.2 | |||||
3-Year EPS without NRI Growth Rate | 29.6 | |||||
3-Year FCF Growth Rate | 25.5 | |||||
3-Year Book Growth Rate | -38.8 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 83.47 | |||||
9-Day RSI | 82.52 | |||||
14-Day RSI | 80.95 | |||||
6-1 Month Momentum % | -39.59 | |||||
12-1 Month Momentum % | -74.47 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.24 | |||||
Quick Ratio | 4.24 | |||||
Cash Ratio | 3.96 | |||||
Days Payable | 32416.29 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -20.7 | |||||
Shareholder Yield % | -21.7 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -143.65 | |||||
ROA % | -118.07 | |||||
ROIC % | -206.99 | |||||
ROC (Joel Greenblatt) % | -8057.78 | |||||
ROCE % | -141.99 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 3.39 | |||||
Price-to-Tangible-Book | 4.91 | |||||
EV-to-EBIT | -3.44 | |||||
EV-to-EBITDA | -3.86 | |||||
EV-to-FCF | -4.63 | |||||
Price-to-Net-Current-Asset-Value | 5.96 | |||||
Price-to-Net-Cash | 6.51 | |||||
Earnings Yield (Greenblatt) % | -29.07 | |||||
FCF Yield % | -18.11 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Coegin Pharma Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | |||
EPS (TTM) (kr) | -2.658 | ||
Beta | 1 | ||
Volatility % | 110.04 | ||
14-Day RSI | 80.95 | ||
14-Day ATR (kr) | 0.498953 | ||
20-Day SMA (kr) | 4.2035 | ||
12-1 Month Momentum % | -74.47 | ||
52-Week Range (kr) | 2.43 - 11.040281 | ||
Shares Outstanding (Mil) | 20.34 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Coegin Pharma Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Coegin Pharma Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Coegin Pharma Frequently Asked Questions
What is Coegin Pharma(NGM:COEGIN)'s stock price today?
When is next earnings date of Coegin Pharma(NGM:COEGIN)?
Does Coegin Pharma(NGM:COEGIN) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |